Navigation Links
National Changing Diabetes Program Supports Improvements in Health Cost Estimates

WASHINGTON, Sept. 1 /PRNewswire/ -- The National Changing Diabetes((R) )Program (NCDP), a program of Novo Nordisk, commends Representative Donna M. Christensen, M.D. (D-VI) and Michael C. Burgess, M.D. (R-TX) for sponsoring legislation that will lead to a more accurate assessment of the cost and benefits of preventive health, including preventing complications and delaying progression of chronic diseases such as diabetes.

The bipartisan Preventive Health Savings Act of 2009 (HR 3148), introduced Thursday, July 9, 2009, calls on the Congressional Budget Office (CBO) to weigh clinical or observational studies when modeling projected costs and savings related to preventive health, and in certain circumstances, look beyond the traditional 10-year budget window. These concepts, supported by researchers at the University of Chicago in a paper published today in Health Affairs, can inform the health care reform debate that will be taken up by Congress this fall.

Currently, the CBO, which provides Congress with impartial analyses of the costs of federal programs, uses traditional economic and actuarial approaches to assess the financial impact or "scores'' of health programs across a 10-year window of time. But in many cases, for chronic, progressive diseases such as diabetes, the true value of prevention and improved treatment outcomes become apparent only when assessed over a longer time period.

"Health care reform represents a once-in-a-lifetime opportunity for creating a system which values prevention, but this promise will not be fully realized without modernizing the way Congress scores preventive health legislation," Congresswoman Christensen said. "The Preventive Health Savings Act requires CBO to conduct an initial analysis to determine whether the preventive health measure would result in substantial savings outside the scoring window, and if those savings exist, CBO must include an estimate and description of those future-year savings in its budget projections."

"As a doctor, I know an ounce of prevention is worth a pound of cure. Preventive measures can save money in the long-term,'' said Representative Burgess. "Today the federal budget scoring process inadvertently skews Congressional decision-making to the short term. This bill calls on the CBO to adjust their metrics and provide Congress accurate 'scoring' of both the long term costs and benefits of preventive health."

Science has pointed toward promising interventions that improve the lives of people living with diabetes. Large studies have shown that early, intensive treatment to reduce blood glucose levels can delay or prevent debilitating and costly complications of diabetes, such as heart disease, stroke, blindness, kidney failure and amputation.

"It is essential for Congress to realistically consider the financial benefits of prevention. Research has shown that prevention measures ranging from early screening to having the tools to successfully manage diabetes are the cost-effective actions we need to take to stem the tide of the diabetes epidemic," said Janel Wright, Chair of the American Diabetes Association's Advocacy Committee.

"By including epidemiological data - the results of clinical trials and other studies that show the impact of prevention programs and good disease management - and better modeling in making its projections, the CBO can provide more accurate information to Congress," said Bob Doherty, Senior Vice President, Governmental Affairs and Public Policy, American College of Physicians.

Chronic diseases are the leading cause of death and disability in the United States, and treatment of these diseases accounts for 75% of national health care spending. Diabetes alone already affects nearly 24 million Americans and is expected to rise to 50 million by 2025.

"Vision benefits are often seen as non-core health care, but a recent study demonstrated early detection of chronic diseases through eye exams translated into significant cost savings for companies," said Rob Lynch, President and CEO, VSP Vision Care. "Results suggest that large employers such as the U.S. Federal Government, which includes over 8 million employees, dependents and retirees, could save an estimated $423 million annually in potential cost avoidance due to early detection through eye exams."

Diabetes cost the U.S. an estimated $218 billion in 2007, in medical care and lost productivity. A report commissioned by NCDP found the federal government spends nearly $80 billion annually to treat people with diabetes and its complications, while only $4 billion is spent on disease prevention and health promotion activities that could reverse or delay the course of the disease.

"Much of the healthcare debate is going to focus on chronic disease,'' says Michael J. O'Grady, Ph.D., Senior Fellow at the National Opinion Research Center at the University of Chicago, who conducted research for NCDP that was the focus of a briefing on Capitol Hill that was sponsored by Reps. Christensen and Burgess. "The whole point of this effort is to arrive at non-partisan, rigorous, science-based estimates that inform policymakers so they have the most accurate and comprehensive information to make the best decisions.''

"Congress needs solid, scientific information to make the choices needed for Americans in the 21st century," said Dana Haza, senior director of NDCP, a diabetes leadership initiative by Novo Nordisk to drive health systems change at the national and local level. "For the first time, Congress will have a comprehensive estimate of the aggregate costs and savings from preventive health and how CBO arrived at its calculations," said Haza.

"Disease prevention and improved care coordination, along with delivery system reform, are at the heart of controlling the high and rising cost of health care," said Ken Thorpe, Ph.D., executive director, the Partnership to Fight Chronic Disease. "We need to do all we can to provide Congress with a better understanding of how disease prevention can both reduce costs and improve the quality of life for all Americans."

"Diabetes costs the nation $218 billion each year in medical expenses and lost productivity. Yet the evidence shows that with early, aggressive treatment, many of the costly and debilitating complications of diabetes can be delayed - or avoided entirely," said Lana Vukovljak, MA, MS, Chief Executive Officer, American Association of Diabetes Educators (AADE). "But it takes an investment up front, in the early years of the disease, to head off huge expenses years later."

About the National Changing Diabetes((R)) Program

The National Changing Diabetes((R)) Program (NCDP) is a multi-faceted initiative that brings together leaders in diabetes and policy to improve the lives of people with diabetes. NCDP strives to create change in the U.S. health care system to provide dramatic improvement in the prevention and care of diabetes. Launched in 2005, NCDP is a program of Novo Nordisk. For more information, please visit or

About Novo Nordisk

Novo Nordisk is a healthcare company with an 86-year history of innovation and achievement in diabetes care. The company has the broadest diabetes product portfolio in the industry, including the most advanced products within the area of insulin delivery systems. In addition to diabetes care, Novo Nordisk has a leading position within areas such as hemostasis management, growth hormone therapy, and hormone therapy for women. Novo Nordisk's business is driven by the Triple Bottom Line: a commitment to social responsibility to employees and customers, environmental soundness and economic success. With headquarters in Denmark, Novo Nordisk employs more than 27,550 employees in 81 countries, and markets its products in 179 countries. Novo Nordisk's B shares are listed on the stock exchanges in Copenhagen and London. Its ADRs are listed on the New York Stock Exchange under the symbol 'NVO'. For global information, visit; for United States information, visit

SOURCE Novo Nordisk
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. National guideline released for the treatment of hoarseness
2. New National Poll Finds Americans Strongly Opposed to Cutting Medicare Payments for Nursing Home Care as a Means of Financing Health Care Reform
3. Noteworthy Medical Systems Demonstrates National Health Information Network (NHIN) Interoperability
4. Health Robotics Expands CytoCare(TM) Global Presence With National Taiwan University Hospital and Pinnaclemed
5. Abbott Launches Next-Generation XIENCE PRIME(TM) Drug Eluting Stent in International Markets
6. Varian Medical Systems Adds RapidArc(R) and Image Guidance to New Low Energy Treatment Platform for Radiation Therapy in International Cancer Clinics
7. ReBuilder Medical Technologies, Inc. Announces Negotiations with National Medicare Provider
8. Larta Institute Wins National Science Foundation (NSF) Contract
9. PRA International to Host Audio Conference
10. DaVita to Present Three Abstracts for the International Society for Peritoneal Dialysis
11. International Travel Raises Risk of Typhoid
Post Your Comments:
(Date:12/1/2015)... Viejo, CA (PRWEB) , ... December 01, 2015 , ... ... length of footage, and with full control over customization, the possibilities are truly endless, ... frame rate, position randomization, overlay depth position, vertical flip, horizontal flip, depth of field ...
(Date:12/1/2015)... ... December 01, 2015 , ... ... receiving the 2015 HSJ Acute Sector Innovation Award on November 18th. This prestigious ... care experience, and propose exciting enhancements to the medical landscape. , The UCLH ...
(Date:11/30/2015)... Cary, NC (PRWEB) , ... November 30, 2015 ... ... Dominique Dawes, Amanda Beard and Brooke Bennett are collaborating with brands across various ... , These four influential figures make up an elite group of Gold Medal ...
(Date:11/30/2015)... , ... December 01, 2015 , ... ... Christina Colon as a 2015-2016 inductee into its VIP Woman of the ... NAPW is the nation’s leading networking organization exclusively for professional women, boasting 850,000 ...
(Date:11/30/2015)... (PRWEB) , ... November 30, 2015 , ... ... programs of the19th Bi-National Convention of the Federation of Philippine American Chambers of ... in Las Vegas, Nevada. , 1Heart Caregiver Services, as an active delegate ...
Breaking Medicine News(10 mins):
(Date:12/1/2015)... --  MabVax Therapeutics Holdings, Inc . (OTCQB: MBVX), a ... an Investigational New Drug Application (IND) with the U.S. ... fully human antibody product HuMab 5B1 as a therapeutic ... the Phase I clinical trial early in 2016. ... planned Phase I trial will evaluate the safety, tolerability ...
(Date:12/1/2015)... 2015  Booth #3506 – Claymount is featuring its full ... of the Radiological Society of North America ... Based in the Netherlands , Claymount is ... (NYSE: VAR ) and is one of the world,s ... state automatic exposure control systems for controlling dose during medical ...
(Date:12/1/2015)... , Dec. 1, 2015  Lexicon Pharmaceuticals, ... that top-line data from its TELECAST Phase ... in treating carcinoid syndrome in cancer patients ... clinical benefit observed in its pivotal TELESTAR ... a companion to TELESTAR primarily to provide ...
Breaking Medicine Technology: